Synovitis is inflammation of the synovial membrane lining the inner surface of the joint capsule, accompanied by fluid (effusion) accumulation in the joint cavity. It can affect any joint but most commonly involves the knee, hip, and shoulder. Without treatment, chronic synovitis destroys articular cartilage and leads to arthrosis. Treatment in Germany includes precise cause identification, minimally invasive methods, and innovative MIBRAR® therapy for synovial membrane and cartilage restoration.
The synovial membrane produces synovial fluid that lubricates and nourishes articular cartilage, removes metabolic waste from the joint, and provides immune defense. During inflammation, the membrane thickens and produces excess fluid — the joint swells, hurts, and movement becomes limited. Inflammatory mediators damage articular cartilage, creating a vicious cycle: synovitis leads to cartilage damage which causes more inflammation.
Synovitis may be traumatic (from meniscus or ligament injuries), reactive from arthrosis (cartilage fragments irritate the synovium), rheumatic from rheumatoid arthritis (autoimmune inflammation), infectious/septic (bacterial — requiring emergency treatment), crystal-induced (gout or pseudogout), or pigmented villonodular (benign synovial tumor).
Joint swelling is the hallmark — the "ballooning" appearance with floating patella sign in the knee. Pain is dull and distending, worsening with movement. Local warmth and redness occur with infectious and crystal synovitis. Morning stiffness characterizes rheumatic forms. Emergency signs (suspected septic synovitis) include fever, marked redness, hot skin, rapid swelling, and general malaise — requiring immediate aspiration.
Ultrasound rapidly visualizes effusion, synovial thickening, and cysts. Joint aspiration is the key method — fluid analysis determines cell count, bacteriology (culture), and crystals (polarization microscopy), distinguishing aseptic from infectious and crystal synovitis. MRI evaluates the synovial membrane, cartilage, menisci, and ligaments, identifying the cause. Radiography assesses arthrosis degree and chondrocalcinosis. Laboratory tests include ESR, CRP, rheumatoid factor, and uric acid.
Joint aspiration provides immediate relief by reducing intra-articular pressure. NSAIDs control inflammation and pain. Intra-articular corticosteroid injections offer powerful anti-inflammatory effect for non-infectious synovitis (limited to 3–4 per year per joint). Hyaluronic acid improves lubrication in chronic arthrosis-related synovitis. Physiotherapy includes cryotherapy in the acute phase, ultrasound, and magnetotherapy. Exercise therapy strengthens peri-articular muscles and restores proprioception. Treatment of underlying disease is essential — disease-modifying therapy for rheumatoid arthritis, uricosurics for gout.
Synovitis (Synoviten) is included in the indications for MIBRAR® technology. Rather than cortisone-based inflammation suppression, MIBRAR® offers tissue regeneration and cause elimination. The anti-inflammatory effect of ARC's potent factors works without cortisone and doesn't weaken cartilage or ligaments. Synovial membrane regeneration restores normal synovial structure through mesenchymal stem cells and growth factors. Articular cartilage regeneration simultaneously addresses concomitant arthrosis. Cause elimination through MIBRAR® micro-arthroscopy removes the underlying problem (meniscal flap, loose body) while transplanting ARC. Over 11,000 CGF method applications without significant side effects.
Arthroscopic synovectomy removes inflamed synovial membrane through 2 punctures, indicated for chronic recurrent, pigmented villonodular, and refractory rheumatic synovitis. Arthroscopic lavage washes out inflammatory mediators, cartilage fragments, and fibrin. Loose body removal addresses synovitis caused by chondromatosis. Cause treatment includes meniscus repair, ligament stabilization, and osteophyte removal.
| Service | Price, € | Note |
|---|---|---|
| Diagnostics (ultrasound + MRI + aspiration) | 2,500–5,000 | 1 day |
| MIBRAR® therapy | on request | outpatient |
| Arthroscopic synovectomy | 6,000–10,000 | 1–2 days inpatient |
All treatment prices in Germany.
Germany offers precise differential diagnosis through aspiration with complete fluid analysis, MIBRAR® therapy providing anti-inflammatory and regenerative effects without cortisone, simultaneous cause treatment and cartilage restoration, minimally invasive arthroscopy at specialized clinics, a multidisciplinary approach (orthopedist + rheumatologist), and multilingual assistance. Chronic synovitis signals serious joint pathology — contact us for expert treatment in Germany.
Or send us a message:
